5y

China shoppers splash the cash in world’s biggest spending spree

Alibaba, which began its sale on November 1, has already raked in 372.3 billion yuan

5y

Japan's Toshiba retreats from coal-fired power stations

Announcement comes after Prime Minister Yoshihide Suga sets  2050 deadline for the world’s third-largest economy to become carbon-neutral

5y

Qatar puts up ‘for sale’ sign with new property visas

Scheme is  latest in  series of measures designed to diversify Qatar’s economy away from fossil fuels and attract foreign capital 

5y

Barclays finances more fossil fuel firms despite green vow: NGOs

Barclays provided US$24.58 billion to major fossil fuel companies in the nine months ending in September, compared with US$24.38 billion a year earlier

5y

Bursa opens easier amid profit-taking

FBM KLCI sheds 10.49 points to 1,564.58 after opening 2.38 points lower at 1,572.69

5y

Boeing sees more cancelled orders for 737 MAX

Aircraft could get green light to return to service as soon as November 18

5y

Apple starts selling Macs with proprietary chips

M1 chip allows computers to operate more like iPhones

5y

US shares end mixed after Covid-19 vaccine high fades

Optimism following announcement by Pfizer, BioNTech tempered by realisation that economic gains will likely not be felt until late 2021

5y

India antitrust watchdog probes Google’s payment app

Ombudsman also looking into Google plan that requires some developers to pay a 30% commission on in-app purchases

5y

Tropicana to acquire two plots of land worth RM402.5 mil in Pahang

Measuring 124.64ha in total, they will be acquired through Elkwood Realty Sdn Bhd and Snowflakes Realty Sdn Bhd

5y

Ringgit surges against greenback at close

Economists attribute ringgit’s sharp rise to US election results

5y

Financial risks increase as pandemic persists, says US Fed

Falling business, household earnings and rising business borrowing leaves households and firms more vulnerable to future shocks

5y

Asia markets extend global rally on vaccine hope

Wall Street and European shares soared when US pharmaceutical giant Pfizer and its German partner BioNTech announced results of their Phase 3 trial